These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 10942172

  • 1. A comparison of carvedilol and metoprolol antioxidant activities in vitro.
    Lysko PG, Webb CL, Gu JL, Ohlstein EH, Ruffolo RR, Yue TL.
    J Cardiovasc Pharmacol; 2000 Aug; 36(2):277-81. PubMed ID: 10942172
    [Abstract] [Full Text] [Related]

  • 2. Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure.
    Kukin ML, Kalman J, Charney RH, Levy DK, Buchholz-Varley C, Ocampo ON, Eng C.
    Circulation; 1999 May 25; 99(20):2645-51. PubMed ID: 10338457
    [Abstract] [Full Text] [Related]

  • 3. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
    Feuerstein GZ, Yue TL, Cheng HY, Ruffolo RR.
    J Hypertens Suppl; 1993 Jun 25; 11(4):S41-8. PubMed ID: 8104241
    [Abstract] [Full Text] [Related]

  • 4. Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model.
    Feuerstein G, Liu GL, Yue TL, Cheng HY, Hieble JP, Arch JR, Ruffolo RR, Ma XL.
    Eur J Pharmacol; 1998 Jun 26; 351(3):341-50. PubMed ID: 9721026
    [Abstract] [Full Text] [Related]

  • 5. Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property.
    Yuan Z, Shioji K, Kihara Y, Takenaka H, Onozawa Y, Kishimoto C.
    Am J Physiol Heart Circ Physiol; 2004 Jan 26; 286(1):H83-90. PubMed ID: 14684360
    [Abstract] [Full Text] [Related]

  • 6. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
    Yue TL, Cheng HY, Lysko PG, McKenna PJ, Feuerstein R, Gu JL, Lysko KA, Davis LL, Feuerstein G.
    J Pharmacol Exp Ther; 1992 Oct 26; 263(1):92-8. PubMed ID: 1357162
    [Abstract] [Full Text] [Related]

  • 7. Neuroprotective activities of carvedilol and a hydroxylated derivative: role of membrane biophysical interactions.
    Lysko PG, Lysko KA, Webb CL, Feuerstein G, Mason PE, Walter MF, Mason RP.
    Biochem Pharmacol; 1998 Dec 15; 56(12):1645-56. PubMed ID: 9973186
    [Abstract] [Full Text] [Related]

  • 8. Beta-blockade in heart failure: a comparison of carvedilol with metoprolol.
    Sanderson JE, Chan SK, Yip G, Yeung LY, Chan KW, Raymond K, Woo KS.
    J Am Coll Cardiol; 1999 Nov 01; 34(5):1522-8. PubMed ID: 10551702
    [Abstract] [Full Text] [Related]

  • 9. Effects of carvedilol on oxidative stress in human endothelial cells and healthy volunteers.
    Fahlbusch SA, Tsikas D, Mehls C, Gutzki FM, Böger RH, Frölich JC, Stichtenoth DO.
    Eur J Clin Pharmacol; 2004 Apr 01; 60(2):83-8. PubMed ID: 15004731
    [Abstract] [Full Text] [Related]

  • 10. Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats.
    Yaoita H, Sakabe A, Maehara K, Maruyama Y.
    Circulation; 2002 Feb 26; 105(8):975-80. PubMed ID: 11864928
    [Abstract] [Full Text] [Related]

  • 11. Effects of beta-blocker therapy on high sensitivity c-reactive protein, oxidative stress, and cardiac function in patients with congestive heart failure.
    Nagatomo Y, Yoshikawa T, Kohno T, Yoshizawa A, Anzai T, Meguro T, Satoh T, Ogawa S.
    J Card Fail; 2007 Jun 26; 13(5):365-71. PubMed ID: 17602983
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of carvedilol and metoprolol on isoprenaline-induced changes in beta-adrenoceptor density and systolic function in rat cardiac myocytes.
    Flesch M, Ettelbrück S, Rosenkranz S, Maack C, Cremers B, Schlüter KD, Zolk O, Böhm M.
    Cardiovasc Res; 2001 Feb 01; 49(2):371-80. PubMed ID: 11164847
    [Abstract] [Full Text] [Related]

  • 13. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
    Ruffolo RR, Feuerstein GZ.
    Cardiovasc Drugs Ther; 1997 May 01; 11 Suppl 1():247-56. PubMed ID: 9211017
    [Abstract] [Full Text] [Related]

  • 14. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
    Hanada K, Asari K, Saito M, Kawana J, Mita M, Ogata H.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):194-200. PubMed ID: 18534575
    [Abstract] [Full Text] [Related]

  • 15. Metabolic effects of beta-adrenoceptor antagonists with special emphasis on carvedilol.
    Kveiborg B, Christiansen B, Major-Petersen A, Torp-Pedersen C.
    Am J Cardiovasc Drugs; 2006 Jul 28; 6(4):209-17. PubMed ID: 16913822
    [Abstract] [Full Text] [Related]

  • 16. Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis.
    Packer M, Antonopoulos GV, Berlin JA, Chittams J, Konstam MA, Udelson JE.
    Am Heart J; 2001 Jun 28; 141(6):899-907. PubMed ID: 11376302
    [Abstract] [Full Text] [Related]

  • 17. Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model.
    Gao F, Chen J, Lopez BL, Christopher TA, Gu J, Lysko P, Ruffolo RR, Ohlstein EH, Ma XL, Yue TL.
    Eur J Pharmacol; 2000 Oct 06; 406(1):109-16. PubMed ID: 11011041
    [Abstract] [Full Text] [Related]

  • 18. Randomized, double-blind comparison of acute beta1-blockade with 50 mg metoprolol tartrate vs 25 mg carvedilol in normal subjects.
    Billeh R, Hirsh D, Barker C, Jorgensen B, Jeger R, Ramanathan K, Tseng CH, Hudaihed A, Haas F, Jorde UP.
    Congest Heart Fail; 2006 Oct 06; 12(5):254-7. PubMed ID: 17033273
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of heart mitochondrial lipid peroxidation by non-toxic concentrations of carvedilol and its analog BM-910228.
    Santos DJ, Moreno AJ.
    Biochem Pharmacol; 2001 Jan 15; 61(2):155-64. PubMed ID: 11163330
    [Abstract] [Full Text] [Related]

  • 20. Carvedilol exerts more potent antiadrenergic effect than metoprolol in heart failure.
    Kohno T, Yoshikawa T, Yoshizawa A, Nakamura I, Anzai T, Satoh T, Ogawa S.
    Cardiovasc Drugs Ther; 2005 Oct 15; 19(5):347-55. PubMed ID: 16382297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.